Prevalence of cancer in the Afro-Caribbean population presenting dermatomyositis and anti-synthetase syndrome: A preliminary study conducted at Pointe-à-Pitre University Hospital, 2000-2012;Prévalence des cancers dans la population afro-caribéenne atteinte de dermatomyosite et de syndrome des anti-synthétases: Étude préliminaire au CHU de Pointe-à-Pitre, 2000-2012

Annales de Dermatologie et de Venereologie

Volumn 141, Issue 10, 2014, Pages 575-580

  Tersiguel, A C ^a   Longueville, C ^a   Beltan, E ^a   Vincent, T ^b   Tressieres B ^a   Cordel, N ^a  

^a Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Afro Caribbean; Anti synthetase syndrome; Cancer; Caribbean; Dermatomyositis

Indexed keywords

ADOLESCENT; ADULT; AFRICAN CARIBBEAN; ANTISYNTHETASE SYNDROME; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; ONSET AGE; RETROSPECTIVE STUDY; AGED; BLACK PERSON; COMORBIDITY; CROSS-SECTIONAL STUDY; ETHNOLOGY; GUADELOUPE; HEALTH SURVEY; MIDDLE AGED; MYOSITIS; NEOPLASMS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; GUADELOUPE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MYOSITIS; NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84913620611     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2014.04.112     Document Type: Article

References (25)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
2. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patientswith dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41-5.
3. Neri R, Simone B, Iacopetti V, Iacopetti G, Pepe P, d'Ascanio A, et al. Cancer-associated myositis: a 35-year retrospectivestudy of a monocentric cohort. Rheumatol Int 2014;34:575-9.
4. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in derma-tomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100.
5. Legault D, McDermott J, Crous-Tsanaclis AM, Boire G. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. JRheumatol 2008;35:169-71.
6. Rozelle A, Trieu S, Chung L. Malignancy in the setting of theanti-synthetase syndrome. J Clin Rheumatol 2008;14:285-8.
7. Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Bey-non HLC. Jo-1 syndrome with associated poorly differentiatedadenocarcinoma. Rheumatology (Oxford) 2004;43:389-90.
8. Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, et al. Comparison of long-term outcome between anti-Jo1- andanti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 2012;11:739-45.
9. O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, et al. HLA polymorphisms in African-Americans with idiopathic inflammatory myopathy: allelicprofiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 2006;54:3670-81.
10. Hu WJ, Chen DL, Min HQ. Study of 45 cases of nasopha-ryngeal carcinoma with dermatomyositis. Am J Clin Oncol 1996;19:35-8.
11. Teo P, Tai TH, Choy D. Nasopharyngeal carcinoma with derma-tomyositis. Int J Radiat Oncol Biol Phys 1989;16:471-4.
12. Diallo M, Fall AK, Diallo I, Diédhiou I, Ba PS, Diagne M, et al. Dermatomyosites et polymyosites : 21 cas au Sénégal. Med Trop 2010;70:166-8.
13. Ríos G. Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myo-pathies. J Clin Rheumatol 2005;11:153-6.
14. Travassos AR, Borges-Costa J, Filipe P, Marques MS. Mali-gnancy associated with dermatomyositis - a retrospectivesingle-center study with 33 patients. Acta Reumatol Port 2013;38:92-7.
15. Chinoy H, Fertig N, Oddis CV, Ollier WER, Cooper RG. Thediagnostic utility of myositis autoantibody testing for predic-ting the risk of cancer-associated myositis. Ann Rheum Dis 2007;66:1345-9.
16. Troyanov Y, Targoff IN, Tremblay J-L, Goulet J-R, Raymond Y. Novel classification of idiopathic inflammatory myopathiesbased on overlap syndrome features and autoantibodies: ana-lysis of 100 French Canadian patients. Medicine (Baltimore)2005;84:231-49.
17. Callen JP. When and how should the patient with dermatomyo-sitis or amyopathic dermatomyositis be assessed for possiblecancer? Arch Dermatol 2002;138:969-71.
18. Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, et al. Routine vs extensive malignancy search for adult dermatomyo-sitis and polymyositis: a study of 40 patients. Arch Dermatol 2002;138:885-90.
19. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy indermatomyositis and polymyositis: a case-control study. Br JDermatol 2001;144:825-31.
20. Limaye V, Luke C, Tucker G, Hill C, Lester S, Blumbergs P, et al. The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatorymyositis. Rheumatol Int 2013;33:965-71.
21. Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, et al. Factors associated with underlying malignancy ina retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) 2009;88:91-7.
22. Cadelis G, Kaddah S, Bhakkan B, Quellery M, Deloumeaux J.Épidémiologie et incidence du cancer bronchique primitif dansune région à faible consommation tabagique : la Guadeloupe. Données 2008-2009 du registre des cancers. Rev Mal Respir 2013;30:537-48.
23. Kadhel P, Janky E, Multigner L. Incidence et mortalitédes cancers gynécologiques en Guadeloupe. Bull Cancer 2009;96:157-64.
24. Chérin P, Marie I. Nouveaux critères diagnostiques etd'évaluation des polymyosites et des dermatomyosites. Rev Med Interne 2005;26:361-7.
25. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Inci-dence of malignant disease in biopsy-proven inflammatorymyopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-95.